<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    China Biologic Products Holdings, Inc.

    China Biologic Products Holdings, Inc.

    China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrat...

    China Biologic Products Holdings, Inc. (NASDAQ:...

    Filing Type:    PU
    CoverUS, Inc

    CoverUS, Inc

    CoverUS is a privacy-by-design based mHealth platform helping to close financial g...

    CoverUS is a privacy-by-design based mHealth pl...

    Amount Raised:    $750,000.00
    Fundraising Status:    SD
    Filing Type:    CF
    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a clinical-stage biopharmaceutical c...

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a...

    Filing Type:    PU
    Eclipse Diagnostics Inc.

    Eclipse Diagnostics Inc.

    Eclipes Diagnostics develops CANABINOX, a handheld testing device that can accurat...

    Eclipes Diagnostics develops CANABINOX, a handh...

    Amount Raised:    $171,800.00
    Fundraising Status:    EC
    Filing Type:    CF
    GLG Pharma, LLC

    GLG Pharma, LLC

    GLG Pharma is a medical research and pharamaceutical company that develops persona...

    GLG Pharma is a medical research and pharamaceu...

    Fundraising Status:    VT
    Filing Type:    CF
    INMODE LTD.

    INMODE LTD.

    InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical tech...

    InMode Ltd. (Nasdaq: INMD) is a leading global ...

    Filing Type:    PU
    OncoSec Medical Incorporated

    OncoSec Medical Incorporated

    OncoSec Medical Incorporated is a clinical-stage biotechnology company focused on ...

    OncoSec Medical Incorporated is a clinical-stag...

    Filing Type:    PU
    Inovio Pharmaceuticals, Inc.

    Inovio Pharmaceuticals, Inc.

    Inovio is bringing IMMUNO-INGENUITY™ to life and is reshaping the future of trea...

    Inovio is bringing IMMUNO-INGENUITY™ to life ...

    Filing Type:    PU
    Cellectis S.A.

    Cellectis S.A.

    Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune ...

    Cellectis is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    CytomX Therapeutics, Inc.

    CytomX Therapeutics, Inc.

    CytomX Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...

    CytomX Therapeutics develops Probody™ therape...

    Filing Type:    PU
    Aethlon Medical, Inc.

    Aethlon Medical, Inc.

    At Aethlon Medical, we are a leading developer of immunotherapeutic technologies t...

    At Aethlon Medical, we are a leading developer ...

    Filing Type:    PU
    Corcept Therapeutics Incorporated

    Corcept Therapeutics Incorporated

    Corcept is a pharmaceutical company engaged in the discovery, development and comm...

    Corcept is a pharmaceutical company engaged in ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.